Guidelines for Optimal Patient Outcomes Using Calcium Hydroxylapatite for Jawline Contour

Area of Science:

• Aesthetic Medicine
• Dermatology
• Plastic Surgery

Background:

• Calcium hydroxylapatite (CaHA(+)) is the first FDA-approved injectable filler for improving moderate-to-severe jawline contour loss.
• CaHA(+) offers contour and support for tissue, making it suitable for jawline augmentation.
• Clinicians need awareness of best practices for CaHA(+) use in jawline contouring.

Purpose of the Study:

• To provide guidance on best practices for patient assessment.
• To outline the on-label use of CaHA(+) for jawline rejuvenation and augmentation.

Main Methods:

• A 2-hour roundtable discussion was held with 5 expert clinicians.
• Discussions focused on patient selection, CaHA(+) injection technique, and safety measures.
• Guidance was developed to support optimal clinical use of CaHA(+) for jawline treatments.

Main Results:

• Common CaHA(+) applications include rejuvenation of the prejowl sulcus, jawline recontouring, and gonial angle definition.
• Gonial angle improvement is a popular procedure across genders and ages.
• Case studies and technique variations were presented.

Conclusions:

• Calcium hydroxylapatite (CaHA(+)) is an ideal filler for jawline augmentation due to its rheologic properties.
• CaHA(+) enables the achievement of defined contours and angles for effective jawline enhancement.
• Appropriate injection techniques lead to high patient satisfaction.